Plain-English translation of NCT06405945 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand which genetic markers (small differences in your DNA) make some people more likely to develop cervical cancer. By studying blood samples from thousands of people with different cervical health statuses — from completely healthy to diagnosed with cervical cancer — they hope to identify genetic patterns that could help doctors better predict who is at highest risk.
Even though HPV vaccines exist, cervical cancer still causes many deaths worldwide. Scientists have found some genetic clues linked to cervical cancer risk, but these findings haven't been clearly confirmed or validated yet. This study aims to confirm which genetic markers truly matter and could eventually help doctors identify high-risk patients earlier.
You likely qualify if…
You likely don't qualify if…
You would attend a screening visit where a blood sample is collected for genetic testing. You would be placed into one of four groups based on your cervical health status: completely healthy, mild changes, more serious changes, or cervical cancer diagnosis. After your initial visit, you would stay in contact with the research team for five years, likely for follow-up appointments to track your cervical health status over time.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
China